Explore the words cloud of the TreatStroke project. It provides you a very rough idea of what is the project "TreatStroke" about.
The following table provides information about the project.
CERCARE MEDICAL APS
|Coordinator Country||Denmark [DK]|
|Total cost||114˙405 €|
|EC max contribution||114˙405 € (100%)|
1. H2020-EU.126.96.36.199. (Enhancing the innovation capacity of SMEs)
|Duration (year-month-day)||from 2017-09-29 to 2018-09-28|
Take a look of project's partnership.
|1||CERCARE MEDICAL APS||DK (AARHUS C)||coordinator||114˙405.00|
Short door-to-needle times are critical in acute ischemic stroke, as stroke progresses over time and hence treatment benefits are time dependent as well. It is estimated that about 1.9 million brain cells are lost per minute in untreated stroke cases, which emphasizes the time urgency of stroke care. Early identification of salvageable tissue is crucial in management and treatment of patients suffering from acute ischemic stroke to avoid further tissue injury – and current approaches are time consuming and highly dependent on clinician’s skills.
We at Combat Stroke need an innovation associate (IA) – Biomedical Data Scientist – to aid us in developing a novel fully automated personalized clinical decision support system (CDSS) for optimal treatment of acute ischemic stroke patients – the HTSafe solution under development at CS. Our company is an SME with limited capacity to mobilize the job market and attract highly skilled professionals to continue the development of the HTSafe. Particularly, the demand for data scientists is far outstripping supply worldwide. Job trends data confirms the rise in popularity for the position, showing that the number of job postings for data scientist positions increased by 1700% between 2012 and 2016. Thus, the H2020-INNOSUP initiative will bridge the gap in our company to develop a novel and disruptive product, which has a large commercial potential to Combat Stroke. Moreover, the programme includes a tailored and core EU training to support the development of new skills and competences of the IA.
The international CDSS market is currently worth over €360 million, and it is growing at astonishing 21.5% CAGR to reach over €1.1 billion by 2022. Given the high incidence of IS cases and the high importance of quickly allocating the appropriate therapeutic intervention, we expect to capture a good share of the CDSS market by 2025.
|Manuscripts in preparation for peer-reviewed scientific publications||Documents, reports||2020-01-22 13:57:27|
|Dissemination, communication and exploitation report||Documents, reports||2020-01-22 13:57:27|
|Final report||Documents, reports||2020-01-22 13:57:27|
|Documented performance of the deep neural networks||Documents, reports||2020-01-22 13:57:27|
Take a look to the deliverables list in detail: detailed list of TreatStroke deliverables.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TREATSTROKE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TREATSTROKE" are provided by the European Opendata Portal: CORDIS opendata.